Tactile Systems Technology, Inc. reported a 24% increase in total revenue to $65.3 million for the third quarter of 2022, driven by growth in both airway clearance and lymphedema product lines. The company also delivered significant improvements in profitability, with increased gross, operating, and adjusted EBITDA margins.
Total revenue increased 24% year-over-year to $65.3 million.
Airway clearance products revenue was $11.0 million, compared to $0.9 million in Q3 2021.
Operating loss was $1.6 million, compared to $1.4 million in Q3 2021.
Non-GAAP net income was $1.9 million, compared to non-GAAP net loss of $1.6 million in Q3 2021.
The Company now expects full year 2022 total revenue in the range of $242.0 million to $245.0 million, representing growth of approximately 16% to 18% year-over-year, compared to total revenue of $208.1 million in 2021.
Visualization of income flow from segment revenue to net income
Analyze how earnings announcements historically affect stock price performance